Related Experiment Videos
Hairy leukoplakia after bone marrow transplantation
J B Epstein1, C H Sherlock, R A Wolber
1Medical/Dental Staff, British Columbia Cancer Agency, Vancouver, Canada.
Oral Surgery, Oral Medicine, and Oral Pathology
|June 1, 1993
Summary
Hairy leukoplakia can develop in patients after bone marrow transplants due to severe immunosuppression. These lesions often resolve on their own as the patient
Area of Science:
- Oral Medicine
- Transplantation Immunology
- Virology
Background:
- Hairy leukoplakia is a lesion that can occur in immunocompromised individuals.
- Bone marrow transplantation (BMT) leads to a period of severe immunosuppression.
- The etiology of hairy leukoplakia, particularly post-BMT, requires further elucidation.
Purpose of the Study:
- To investigate the clinical and histological characteristics of hairy leukoplakia in patients following bone marrow transplantation.
- To identify potential viral etiologies, specifically Epstein-Barr virus (EBV) and human papillomavirus (HPV), in post-BMT hairy leukoplakia.
- To assess the natural resolution of these lesions in relation to the recovery of the immune system.
Main Methods:
- Clinical identification and histological assessment of hairy leukoplakia in 10 post-BMT patients.
- In situ hybridization techniques were employed to detect Epstein-Barr virus and human papillomavirus.
- Clinical follow-up was conducted to monitor lesion resolution.
Main Results:
- Hairy leukoplakia was observed in 10 patients post-bone marrow transplantation.
- Epstein-Barr virus was detected in two cases, and human papillomavirus in three cases via in situ hybridization.
- All documented cases of hairy leukoplakia resolved spontaneously without specific therapeutic intervention.
Conclusions:
- Severe immunosuppression following bone marrow transplantation is a likely contributing factor to the development of hairy leukoplakia.
- The resolution of hairy leukoplakia correlates with the gradual recovery from immunosuppression post-transplant.
- Hairy leukoplakia in this context may represent a transient condition linked to the post-transplant immune status.